Pörssitiedote

Johan Wewel appointed as CFO of Ortivus

Ortivus has recruited Johan Wewel as the new Chief Financial Officer and a member of the company's management team.

Ortivus is pleased to announce the appointment of Johan Wewel as the new Chief Financial Officer (CFO). Johan brings nearly three decades of experience in executive positions within companies characterized by profitable growth.

"We are very pleased to welcome Johan Wewel to our team! Johan's extensive and diverse experience from leading positions in growth companies with a focus on profitability will be of great importance to Ortivus." says Gustaf Nordenhök, Ortivus’ CEO.

From 2017 to 2021, Johan served as CFO at Frösunda Omsorg, where he gained valuable experience in a listed environment through the company's financing via listed bonds. Johan's work has primarily focused on service-producing companies, but he also has experience in production and international sales.

In addition to his extensive operational experience in financial management, financing and corporate transactions, Johan has worked as a senior advisor at Carlsquare, providing financial advisory services and assisting clients with mergers and acquisitions, listings, and equity market analysis.

Most recently, Johan held the position of CFO at Ecoclime Group.

“I am excited to join Ortivus at such a pivotal time in its journey,” says Johan Wewel. “I look forward to working closely with the talented team at Ortivus to drive financial excellence and contribute to the company’s success.”

Johan will assume the role of Ortivus CFO on September 1, 2024.

About Ortivus

Ortivus develops and commercialises MobiMed, e-health and medical technology solutions for a safer and more efficient healthcare. The company was founded in 1985 and is today a leading provider of mobile digital solutions for prehospital care, worldwide. Ortivus' innovations are based on in-depth expertise in cardiology as well as decades of development together with users and customers. The company's headquarters are located in Danderyd, Stockholm. The company has, since 1998, a wholly owned subsidiary based in the United Kingdom and since 2022, a wholly owned subsidiary based in Denmark.

MobiMed is a modular platform that connects and enable real-time information sharing throughout the prehospital care chain. It is currently used by over 12,000 paramedics in over 2,700 emergency vehicles. The platform, MobiMed, consists of several product modules that are completely integrated but can also be used stand-alone. MobiMed comprises four main solutions: MobiMed Monitor, that measures, monitors and shares patients' vital parameters and ECG in real-time, MobiMed ePR, - an electronic patient record for decision support, collection of patient data and clinical documentation, MobiMed enRoute, - a tool for navigation and case management, and MobiMed Life - a range of stand-alone defibrillators.

MobiMed saves vital seconds and enable healthcare professionals make the right decisions in critical situations. MobiMed also contributes to improved quality of care and saved resources.

Ortivus Class A and Class B shares are listed on the NASDAQ Stockholm Small Cap list.

Read more about Ortivus at www.ortivus.com